Azmi Nabulsi - 01 Nov 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol
PHAT
Transactions as of
01 Nov 2023
Net transactions value
$0
Form type
4
Filing time
03 Nov 2023, 16:54:25 UTC
Previous filing
17 Jul 2023
Next filing
22 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $0 +32,500 +16% $0.000000 242,067 01 Nov 2023 Direct F1
holding PHAT Common Stock 3,579 01 Nov 2023 By 401(k)
holding PHAT Common Stock 785,700 01 Nov 2023 by Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned with respect to performance stock unit awards granted on July 1, 2020 and January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.